{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:22:09Z","timestamp":1787062929922,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":5662,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.micinf.2008.05.009","type":"journal-article","created":{"date-parts":[[2008,6,20]],"date-time":"2008-06-20T04:14:05Z","timestamp":1213935245000},"page":"908-915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV"],"prefix":"10.1016","volume":"10","author":[{"given":"Yu-ya","family":"Mitsuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuminori","family":"Mizukoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Terahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Yamaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Tsunetsugu-Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2008.05.009_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.micinf.2008.05.009_bib2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.micinf.2008.05.009_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors","volume":"363","author":"Liu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2008.05.009_bib4","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micinf.2008.05.009_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2008.05.009_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM200307313490520","article-title":"Profile of specific antibodies to the SARS-associated coronavirus","volume":"349","author":"Li","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micinf.2008.05.009_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/rmv.492","article-title":"Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine","volume":"16","author":"Tsunetsugu-Yokota","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/427242","article-title":"Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice","volume":"191","author":"Greenough","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micinf.2008.05.009_bib9","doi-asserted-by":"crossref","first-page":"7195","DOI":"10.1128\/JVI.79.11.7195-7206.2005","article-title":"Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein","volume":"79","author":"Sainz","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib10","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1128\/JVI.79.2.1252-1261.2005","article-title":"Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1","volume":"79","author":"Zwick","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11373-005-9004-3","article-title":"Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)","volume":"12","author":"Lai","year":"2005","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.micinf.2008.05.009_bib12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/JVI.80.2.941-950.2006","article-title":"Monoclonal antibodies targeting the HR2 domain and the region immediately upstream of the HR2 of the S protein neutralize in vitro infection of severe acute respiratory syndrome coronavirus","volume":"80","author":"Lip","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib13","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/JVI.78.13.6938-6945.2004","article-title":"Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib14","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1128\/JVI.79.6.3401-3408.2005","article-title":"B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein","volume":"79","author":"Zhong","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/intimm\/dxh143","article-title":"A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice","volume":"16","author":"Takasuka","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.micinf.2008.05.009_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.7883\/yoken.JJID.2005.88","article-title":"Immunological detection of severe acute respiratory syndrome coronavirus by monoclonal antibodies","volume":"58","author":"Ohnishi","year":"2005","journal-title":"Jpn. J. Infect. Dis."},{"key":"10.1016\/j.micinf.2008.05.009_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.virol.2006.03.020","article-title":"Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs","volume":"351","author":"Ishii","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2008.05.009_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/CDLI.8.2.297-302.2001","article-title":"A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization","volume":"8","author":"Yoo","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.micinf.2008.05.009_bib19","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region","volume":"79","author":"Chen","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2008.05.009_bib21","doi-asserted-by":"crossref","first-page":"10315","DOI":"10.1128\/JVI.01138-06","article-title":"Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus","volume":"80","author":"Shih","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib22","doi-asserted-by":"crossref","first-page":"11638","DOI":"10.1128\/JVI.79.18.11638-11646.2005","article-title":"Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain","volume":"79","author":"Yi","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib23","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1073\/pnas.0307140101","article-title":"Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association","volume":"101","author":"Sui","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micinf.2008.05.009_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/424121a","article-title":"SARS: what have we learned?","volume":"424","author":"Pearson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2008.05.009_bib25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.virol.2006.09.029","article-title":"Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse","volume":"361","author":"Coughlin","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2008.05.009_bib26","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1128\/JVI.02377-07","article-title":"Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge","volume":"82","author":"Rockx","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2008.05.009_bib27","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.0701000104","article-title":"Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.micinf.2008.05.009_bib28","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS. Med."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457908001469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457908001469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:22:13Z","timestamp":1761142933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457908001469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S1286457908001469"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2008.05.009","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2008.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}